Historical dataset showing Australia infant mortality rate by year from 1950 to 2025.

Mortality rate, infant, male (per 1,000 live births) in Australia was reported at 3.4 % in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. Australia - Mortality rate, infant, male (per 1,000 live births) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

Mortality rate, infant, female (per 1,000 live births) in Australia was reported at 2.9 % in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. Australia - Mortality rate, infant, female (per 1,000 live births) - actual values, historical data, forecasts and projections were sourced from the World Bank on August of 2025.

UNICEF's country profile for Australia, including under-five mortality rates, child health, education and sanitation data.

Number of infant deaths in Australia was reported at 953 deaths in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. Australia - Number of infant deaths - actual values, historical data, forecasts and projections were sourced from the World Bank on August of 2025.

Historical dataset showing Australia birth rate by year from 1950 to 2025.

Birth rate, crude (per 1,000 people) in Australia was reported at 10.8 % in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. Australia - Birth rate, crude - actual values, historical data, forecasts and projections were sourced from the World Bank on September of 2025.

The statistic shows the 20 countries with the lowest fertility rates in 2024. All figures are estimates. In 2024, the fertility rate in Taiwan was estimated to be at 1.11 children per woman, making it the lowest fertility rate worldwide. Fertility rate The fertility rate is the average number of children born per woman of child-bearing age in a country. Usually, a woman aged between 15 and 45 is considered to be in her child-bearing years. The fertility rate of a country provides an insight into its economic state, as well as the level of health and education of its population. Developing countries usually have a higher fertility rate due to lack of access to birth control and contraception, and to women usually foregoing a higher education, or even any education at all, in favor of taking care of housework. Many families in poorer countries also need their children to help provide for the family by starting to work early and/or as caretakers for their parents in old age. In developed countries, fertility rates and birth rates are usually much lower, as birth control is easier to obtain and women often choose a career before becoming a mother. Additionally, if the number of women of child-bearing age declines, so does the fertility rate of a country. As can be seen above, countries like Hong Kong are a good example for women leaving the patriarchal structures and focusing on their own career instead of becoming a mother at a young age, causing a decline of the country’s fertility rate. A look at the fertility rate per woman worldwide by income group also shows that women with a low income tend to have more children than those with a high income. The United States are neither among the countries with the lowest, nor among those with the highest fertility rate, by the way. At 2.08 children per woman, the fertility rate in the US has been continuously slightly below the global average of about 2.4 children per woman over the last decade.

The size of the Australia Neonatal and Prenatal Devices Market was valued at USD XX Million in 2023 and is projected to reach USD XXX Million by 2032, with an expected CAGR of 4.50% during the forecast period. The growth trajectory of the neonatal and prenatal devices market in Australia is relatively supportive given the increasing attention and investments on maternal and child health, improve in technologies and equipment and the scourge related to complications of pregnancy and ailments of newborn babies. Neonatal and prenatal devices or equipment which comprise of fetal monitors, ultrasound machines, incubators, neonatal ventilators oxygen concentrators, phototherapy among others plays a critical role in promotion and protection of health of both mothers and babies during pregnancy, at delivery and in the baby’s postpartum stage. Some of the market catalysts include increasing trend of the birth of preterm infants and other pregnancy complications in the country. Advanced maternal age, in addition to several lifestyle factors, has made pregnancies high risk. This situation has spurred the demand for sophisticated prenatal and neonatal monitoring devises to prevent high risk pregnancies. These monitoring devises are very crucial in monitoring abnormalities such as fetal distress, the presence of gestational diabetes, preeclampsia and other conditions that need urgent treatment to prevent risk on the mother and baby. Innovations such as NIPT, smart fetal monitoring systems, high-frequency ventilators, and surfactant therapy equipment offer the healthcare industry new ways of providing neonatal as well as prenatal services. Besides even with the distance maternal care is now possible with the help of technologies like triage and tele-monitoring incorporated in the field. This has made it very possible for the health providers to reach and support the health of the pregnant women especially in the far-out areas of Australia. Recent developments include: August 2021: Australian startup ResusRight has raised nearly USD 784,000 to fund a pediatric medical device designed to resuscitate newborn babies safely., July 2021: I-MED Radiology, Australia's leading medical imaging company, agreed to use MRI Online's education and talent management platform for a multi-year period. Thus, such educational training programs are expected to support newborn babies efficiently.. Key drivers for this market are: Rising Incidence of Preterm Births, Increasing Awareness for Prenatal and Neonatal Care. Potential restraints include: Low Birth Rates in the Country. Notable trends are: Incubators Sub-segment Expected to Hold a Significant Market Share.

The Australian neonatal and prenatal devices market is experiencing steady growth, driven by factors such as rising birth rates, increasing prevalence of premature births and low birth weight infants, and advancements in medical technology leading to the development of sophisticated and less invasive devices. The market, valued at approximately $XX million in 2025 (assuming a logical market size based on global trends and the provided CAGR), is projected to expand at a Compound Annual Growth Rate (CAGR) of 4.50% from 2025 to 2033. This growth is fueled by increasing government initiatives to improve maternal and child healthcare infrastructure, along with rising awareness among parents about the importance of prenatal and postnatal care. Key segments within the market, such as prenatal equipment (including ultrasound and fetal monitoring devices) and neonatal equipment (such as incubators and respiratory support systems), are witnessing significant demand. The market's growth, however, faces potential restraints like the high cost of advanced medical devices and the limited reimbursement policies in some healthcare settings. Major players like GE Healthcare, Getinge AB, Koninklijke Philips NV, Natus Medical Incorporated, Vyaire Medical, Medtronic PLC, and Masimo (among others) are actively contributing to market expansion through continuous innovation and strategic partnerships. These companies are focusing on developing cutting-edge devices with enhanced features, improved accuracy, and user-friendliness to cater to the growing demand. Furthermore, the increasing adoption of telemedicine and remote patient monitoring technologies is expected to further drive market expansion, particularly in geographically dispersed regions of Australia. The historical period of 2019-2024 provided a baseline for assessing market growth and predicting future trends, with 2025 serving as the base year for forecasting to 2033. Future market analysis will continue to focus on these key drivers, restraints, and the evolving technological landscape. Recent developments include: August 2021: Australian startup ResusRight has raised nearly USD 784,000 to fund a pediatric medical device designed to resuscitate newborn babies safely., July 2021: I-MED Radiology, Australia's leading medical imaging company, agreed to use MRI Online's education and talent management platform for a multi-year period. Thus, such educational training programs are expected to support newborn babies efficiently.. Key drivers for this market are: Rising Incidence of Preterm Births, Increasing Awareness for Prenatal and Neonatal Care. Potential restraints include: Rising Incidence of Preterm Births, Increasing Awareness for Prenatal and Neonatal Care. Notable trends are: Incubators Sub-segment Expected to Hold a Significant Market Share.

For the week ending August 15, 2025, weekly deaths in England and Wales were 1,405 below the number expected, compared with 1,156 below what was expected in the previous week. In late 2022 and through early 2023, excess deaths were elevated for a number of weeks, with the excess deaths figure for the week ending January 13, 2023, the highest since February 2021. In the middle of April 2020, at the height of the COVID-19 pandemic, there were almost 12,000 excess deaths a week recorded in England and Wales. It was not until two months later, in the week ending June 19, 2020, that the number of deaths began to be lower than the five-year average for the corresponding week. Most deaths since 1918 in 2020 In 2020, there were 689,629 deaths in the United Kingdom, making that year the deadliest since 1918, at the height of the Spanish influenza pandemic. As seen in the excess death figures, April 2020 was by far the worst month in terms of deaths during the pandemic. The weekly number of deaths for weeks 16 and 17 of that year were 22,351, and 21,997 respectively. Although the number of deaths fell to more usual levels for the rest of that year, a winter wave of the disease led to a high number of deaths in January 2021, with 18,676 deaths recorded in the fourth week of that year. For the whole of 2021, there were 667,479 deaths in the UK, 22,150 fewer than in 2020. Life expectancy in the UK goes into reverse In 2022, life expectancy at birth for women in the UK was 82.6 years, while for men it was 78.6 years. This was the lowest life expectancy in the country for ten years, and came after life expectancy improvements stalled throughout the 2010s, and then declined from 2020 onwards. There is also quite a significant regional difference in life expectancy in the UK. In the London borough of Kensington and Chelsea, for example, the life expectancy for men was 81.5 years, and 86.5 years for women. By contrast, in Blackpool, in North West England, male life expectancy was just 73.1 years, while for women, life expectancy was lowest in Glasgow, at 78 years.

In June 2022, it was estimated that around 7.3 percent of Australians were aged between 25 and 29, and the same applied to people aged between 30 and 34. All in all, about 55 percent of Australia’s population was aged 35 years or older as of June 2022. At the same time, the age distribution of the country also shows that the share of children under 14 years old was still higher than that of people over 65 years old. A breakdown of Australia’s population growth Australia is the sixth-largest country in the world, yet with a population of around 26 million inhabitants, it is only sparsely populated. Since the 1970s, the population growth of Australia has remained fairly constant. While there was a slight rise in the Australian death rate in 2022, the birth rate of the country decreased after a slight rise in the previous year. The fact that the birth rate is almost double the size of its death rate gives the country one of the highest natural population growth rates of any high-income country.
National distribution of the population Australia’s population is expected to surpass 28 million people by 2028. The majority of its inhabitants live in the major cities. The most populated states are New South Wales, Victoria, and Queensland. Together, they account for over 75 percent of the population in Australia.

Comprehensive dataset of 9 Birth centers in New South Wales, Australia as of July, 2025. Includes verified contact information (email, phone), geocoded addresses, customer ratings, reviews, business categories, and operational details. Perfect for market research, lead generation, competitive analysis, and business intelligence. Download a complimentary sample to evaluate data quality and completeness.

Comprehensive dataset of 37 Birth centers in Australia as of July, 2025. Includes verified contact information (email, phone), geocoded addresses, customer ratings, reviews, business categories, and operational details. Perfect for market research, lead generation, competitive analysis, and business intelligence. Download a complimentary sample to evaluate data quality and completeness.

Life expectancy at birth, total (years) in Australia was reported at 83.05 years in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. Australia - Life expectancy at birth, total (years) - actual values, historical data, forecasts and projections were sourced from the World Bank on September of 2025.

The Asia-Pacific fetal and neonatal care equipment market, valued at $15.41 billion in 2025, is projected to experience robust growth, driven by a rising birth rate, increasing prevalence of premature births and low birth weight infants, and expanding healthcare infrastructure across the region. Technological advancements in fetal monitoring, neonatal intensive care, and minimally invasive procedures are further fueling market expansion. China, India, and Japan represent significant market segments, accounting for a substantial share of the overall market value, primarily due to their large populations and increasing disposable incomes. However, challenges remain, including high equipment costs, uneven distribution of healthcare resources across the region, and a shortage of skilled medical professionals, particularly in rural areas. The market is segmented into fetal care equipment (fetal dopplers, ultrasound devices, MRI devices, etc.) and neonatal care equipment (incubators, monitoring devices, respiratory support, etc.), with both segments witnessing substantial growth. The demand for advanced non-invasive monitoring technologies and telehealth solutions is also anticipated to contribute significantly to market growth during the forecast period (2025-2033). Competition is intense, with both established multinational corporations and regional players vying for market share. The market's Compound Annual Growth Rate (CAGR) of 7.12% from 2019 to 2025 suggests a continued upward trajectory. Considering this CAGR and the substantial size of the market, we can anticipate continued growth driven by factors such as increased government initiatives focused on improving maternal and child health, rising awareness of advanced neonatal care, and the adoption of innovative technologies. The increasing prevalence of chronic diseases affecting pregnant women and newborns further contributes to the demand for sophisticated fetal and neonatal care equipment. While the Rest of Asia-Pacific region demonstrates significant growth potential, factors such as economic disparities and healthcare infrastructure limitations might influence market penetration. Successful players will need to focus on strategic partnerships, targeted marketing campaigns, and affordable product offerings to capture the market share in developing economies. Recent developments include: In February 2021, Philips completed the acquisition of BioTelemetry Inc., a leading US-based provider of remote cardiac diagnostics and monitoring., In May 2020, Drager launched the Evita V600 and V800 and Babylog VN600 and VN800 devices for the intensive care ventilation of adults and premature babies. The devices were launched for sale across the world.. Key drivers for this market are: Increasing Number of Preterm and Low-weight Births, Growing Technological Advancement in Infant and Maternal Care Products; Increase in the Prevalence of Congenital Anomalies. Potential restraints include: Increasing Number of Preterm and Low-weight Births, Growing Technological Advancement in Infant and Maternal Care Products; Increase in the Prevalence of Congenital Anomalies. Notable trends are: The Incubators Segment is Expected to Show a Significant Growth During the Forecast Period.

Births that occurred by hospital name. Birth events of 5 or more per hospital location are displayed

Life expectancy at birth, male (years) in Australia was reported at 81.1 years in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. Australia - Life expectancy at birth, male (years) - actual values, historical data, forecasts and projections were sourced from the World Bank on September of 2025.

Yearly registered births – breakdown by Month

Life expectancy at birth, female (years) in Australia was reported at 85.1 years in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. Australia - Life expectancy at birth, female (years) - actual values, historical data, forecasts and projections were sourced from the World Bank on September of 2025.